Ayad Al-Katib

460 total citations
17 papers, 317 citations indexed

About

Ayad Al-Katib is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Ayad Al-Katib has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Ayad Al-Katib's work include Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Ayad Al-Katib is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Ayad Al-Katib collaborates with scholars based in United States and Pakistan. Ayad Al-Katib's co-authors include Tarik Hadid, Ramzi M. Mohammad, Maria Dan, Ramzi M. Mohammad, Mitchell R. Smith, Frances W.J. Beck, Khalil Katato, Nayera Hamdy, Nathan R. Wall and Lyle L. Sensenbrenner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Oncotarget.

In The Last Decade

Ayad Al-Katib

17 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayad Al-Katib United States	9	118	95	79	66	59	17	317
Gehong Dong China	8	77 0.7×	91 1.0×	104 1.3×	68 1.0×	64 1.1×	25	290
Kenneth Washenik United States	5	48 0.4×	52 0.5×	47 0.6×	24 0.4×	69 1.2×	7	409
Donata Urbaniak‐Kujda Poland	12	81 0.7×	130 1.4×	87 1.1×	19 0.3×	98 1.7×	37	416
Xiaoying Sun China	12	41 0.3×	56 0.6×	38 0.5×	35 0.5×	29 0.5×	25	393
Ioannis P. Trontzas Greece	11	79 0.7×	153 1.6×	19 0.2×	44 0.7×	97 1.6×	32	338
Nicole L Byers United States	5	40 0.3×	91 1.0×	37 0.5×	26 0.4×	39 0.7×	5	377
Anne Marie Young United Kingdom	6	65 0.6×	308 3.2×	179 2.3×	71 1.1×	19 0.3×	6	405
Jianhong Fu China	9	169 1.4×	128 1.3×	24 0.3×	83 1.3×	114 1.9×	23	388
Anna K. Dewan United States	10	46 0.4×	309 3.3×	115 1.5×	21 0.3×	70 1.2×	24	496
Tetsuo Hashida Japan	9	86 0.7×	76 0.8×	21 0.3×	87 1.3×	71 1.2×	15	341

Countries citing papers authored by Ayad Al-Katib

Since Specialization

Citations

This map shows the geographic impact of Ayad Al-Katib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayad Al-Katib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayad Al-Katib more than expected).

Fields of papers citing papers by Ayad Al-Katib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayad Al-Katib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayad Al-Katib. The network helps show where Ayad Al-Katib may publish in the future.

Co-authorship network of co-authors of Ayad Al-Katib

This figure shows the co-authorship network connecting the top 25 collaborators of Ayad Al-Katib. A scholar is included among the top collaborators of Ayad Al-Katib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayad Al-Katib. Ayad Al-Katib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hadid, Tarik, Ayad Al-Katib, José Binongo, et al.. (2023). Palifermin Compared to Supersaturated Calcium Phosphate Rinse in Prevention of Severe Oral Mucositis after Stem Cell Transplantation in Patients Receiving Radiotherapy-Based Myeloablative Conditioning. SHILAP Revista de lepidopterología. 4(1). 58–67. 1 indexed citations

Hadid, Tarik, et al.. (2020). Coagulation and anticoagulation in COVID-19. Blood Reviews. 47. 100761–100761. 132 indexed citations

Smith, Marc D., et al.. (2019). Lymphomatoid Granulomatosis in a Patient with Chronic Lymphocytic Leukemia and Rapidly Progressing Peribronchovascular Pulmonary Infiltrates. SHILAP Revista de lepidopterología. 2019. 1–5. 2 indexed citations

Khan, Uqba, et al.. (2017). Composite Lymphoma: Opposite Ends of Spectrum Meet. Journal of Clinical Medicine Research. 9(3). 213–215. 4 indexed citations

Amessou, Mohamed, et al.. (2016). Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3). Oncotarget. 7(48). 79203–79216. 4 indexed citations

Singh, Baljit, et al.. (2016). Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor. Case Reports in Cardiology. 2016. 1–4. 12 indexed citations

Aguilar, Javier, Susan Szpunar, Mamta Sharma, et al.. (2011). Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Lymphoproliferative Disorders. Clinical Lymphoma Myeloma & Leukemia. 12(1). 66–69. 16 indexed citations

Smith, Mitchell R., Mary Varterasian, Chatchada Karanes, et al.. (2004). Phase II Study of PEND Chemotherapy in Patients with Refractory/Relapsed Hodgkin Lymphoma. Leukemia & lymphoma. 45(10). 2079–2084. 1 indexed citations

Beck, Frances W.J., et al.. (2004). Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia. International Journal of Molecular Medicine. 14(1). 113–9. 4 indexed citations

10.

Mohammad, Ramzi M., Michael C. Dugan, Sanaa T. Dergham, et al.. (1998). Establishment of a Human Pancreatic Tumor Xenograft Model. Pancreas. 16(1). 19–25. 33 indexed citations

11.

Mohammad, Ramzi M., Frances W.J. Beck, Khalil Katato, et al.. (1998). Potentiation of 2-Chlorodeoxyadenosine Activity by Bryostatin 1 in the Resistant Chronic Lymphocytic Leukemia Cell Line (WSU-CLL): Association with Increased Ratios of dCK/5'-NT and Bax/Bcl-2. Biological Chemistry. 379(10). 1253–1262. 27 indexed citations

12.

Mohamed, Anwar N., et al.. (1996). Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 86(2). 143–146. 18 indexed citations

13.

Varterasian, Mary, Voravit Ratanatharathorn, Joseph P. Uberti, et al.. (1995). Clinical Course and Outcome of Patients with Hodgkin's Disease who Progress after Autologous Transplantation. Leukemia & lymphoma. 20(1-2). 59–65. 16 indexed citations

14.

Smith, Mitchell R., et al.. (1994). Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease. Cancer. 73(4). 1264–1269. 7 indexed citations

15.

Mohammad, Ramzi M., et al.. (1994). Induced Expression of Alpha-Enolase inDifferentiated Diffuse Large Cell Lymphoma. PubMed. 48(1). 37–44. 10 indexed citations

16.

Al-Katib, Ayad, Ramzi M. Mohammad, Khalid M. Khan, et al.. (1993). Bryostatin 1-Induced Modulation of the Acute Lymphoblastic Leukemia Cell Line Reh. Journal of Immunotherapy. 14(1). 33–42. 22 indexed citations

17.

Mohammad, Ramzi M., Anwar N. Mohamed, Mark KuKuruga, Mitchell R. Smith, & Ayad Al-Katib. (1992). A human b-cell lymphoma line with a de novo multidrug resistance phenotype. Cancer. 69(6). 1468–1474. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact